Huvepharma® Announces Optigrid® 45 Medicated Feed Combination Approvals

reading time
Article | 20.01.2021
Blue Bird labels are now available for four combinations with the feed additive.

Global animal health company Huvepharma's Optigrid® 45, ractopamine hydrochloride Type A medicated article a feed additive used to promote weight gain and improve feed efficiency in finishing feedlot cattle, has received U.S. Food & Drug Administration (FDA) approval for combination use with other drug feed additive products in the manufacture of Type B and C medicated feeds. 

Optigrid® 45, which is comprised of the active ingredient ractopamine hydrochloride, can be fed as a complete feed or top dress feed to cattle fed in confinement for slaughter during the last 28-48 days on feed prior to harvest. The combination approvals allow Optigrid® 45 to be used with other feed additives commonly fed to feedlot cattle, including monensin, tylosin and melengestrol. 

The four specific combinations receiving FDA approval include

  • Optigrid® 45 with Monovet® 90 (monensin Type A medicated article)
  • Optigrid® 45 with Monovet® 90 and Tylovet® (tylosin phosphate Type A medicated article)
  • Optigrid® 45 with Monovet® 90 and MGA® (melengestrol)
  • Optigrid® 45 with Monovet® 90, Tylovet® and MGA®

"With the continued need for efficiency in beef production, we are pleased to bring these medicated feed additive combinations with Optigrid® 45 to the cattle industry," said head of U.S. sales and marketing, Rick Cozzitorto. 

Huvepharma has been active in the U.S. animal health market since 2005 providing products for poultry, swine and cattle markets. The company received FDA approval for Optigrid® 45 in June 2020. 

For more information, please contact your Huvepharma sales representative and/or Huvepharma's U.S. customer service team by calling +1 877-994-4883.


global presence

Local support from a global company

Huvepharma® has a distribution network which covers more than 90 countries in 6 continents. Find your nearest Huvepharma® representative today.
Find your local contact
about us


Huvepharma® is a fast-growing, global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health and nutrition products.
more about us

Change country

The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.

To view all products and services, select Global from the dropdown menu or click .




North America


South America

Change language

Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.


United States

Click here to visit the local website or close this popup to stay on the global website.

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now